In some cases, being overweight can help in the fight against cancer, said scientists from Flinders University (Australia). According to a press release on EurekAlert!, experts analyzed the results of clinical trials of the drug atezolizumab, which is used in the treatment of non-small cell lung cancer. As it turned out, the average and high body mass index contributes to better patient sensitivity to treatment with this drug. Overweight and obesity increase the risk of developing malignant tumors.

Mortality was significantly reduced in patients taking an immune control point inhibitor. According to scientists, further research is needed to uncover the mechanisms underlying the paradoxical response to anticancer therapy.

According to WHO estimates, 2.8 million people die every year in the world due to overweight or obesity.

Overweight people are more susceptible to high blood pressure, cholesterol and insulin resistance. It is known that with an increase in body mass index, the risk of developing coronary heart disease, ischemic stroke and type 2 diabetes increases.